Market capitalisation, EUR | 7,068.66 m |
EPS, EUR | -7.47 |
P/B ratio | 73.17 |
P/E ratio | - |
Dividend yield | 0.00% |
Revenue, EUR | 266.72 m |
Net income, EUR | -481.45 m |
Profit margin | -180.51% |
ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
---|---|---|---|---|---|---|---|---|
Harbor Health Care UCITS ETF Accumulating | 9.74% | Equity World Health Care Innovation | 41 | 0.89% | 15 | +6.48% | A2PFPC | IE00BJQTJ848 |
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Distributing | 0.01% | Equity World Multi-Factor Strategy | 3,620 | 0.50% | 62 | +24.68% | WELT0B | IE000FPWSL69 |
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.86% | Equity United States Health Care Biotech | 214 | 0.35% | 32 | +19.86% | A2JDYM | IE00BDZVHG35 |
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Accumulating | 0.01% | Equity World Multi-Factor Strategy | 3,620 | 0.50% | 325 | +25.13% | WELT0A | IE0001UQQ933 |
iShares Nasdaq US Biotechnology UCITS ETF | 0.86% | Equity United States Health Care Biotech | 214 | 0.35% | 440 | +20.83% | A2DWAW | IE00BYXG2H39 |
Fidelity Sustainable Research Enhanced US Equity UCITS ETF Acc | 0.05% | Equity United States Social/Environmental | 201 | 0.20% | 452 | +37.64% | A2P0ZN | IE00BKSBGS44 |